Harm reduction readiness for illicit IV drug use among safety-net primary care practices in the San Fernando Valley

被引:0
|
作者
Kalinoski, Thomas [1 ]
DeWitt, Cassandra [2 ]
Belani, Hrishikesh [1 ]
机构
[1] Olive View UCLA Med Ctr, Dept Internal Med, 14445 Olive View Dr, Sylmar, CA 91342 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA
关键词
Harm reduction; Injection drug use; HIV; Hepatitis C; Communicable disease;
D O I
10.1186/s13690-022-00855-w
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Harm reduction is an accumulation of strategies aimed at preventing adverse health outcomes associated with illicit substance use. Several harm reduction programs and services exist within Los Angeles County (LAC), however their success relies in part on the application of harm reduction principles by local primary care providers serving patients with substance use disorders. This study aims to assess the readiness of patient-centered medical homes in the San Fernando Valley to provide effective harm reduction to patients who use injection drugs and identify barriers to doing so. Methods An online survey was distributed to primary care providers and social workers via email at federally qualified health centers and LAC Department of Health Services clinics in the San Fernando Valley between May and June 2019. It consisted of 22 multiple-choice, Likert scale, and short answer questions. The survey assessed knowledge of injection drug use (IDU), familiarity and utilization of harm-reduction and resources, and self-evaluation of attitudes and skills. Results There were a total of 41 survey respondents across all clinics. Of respondents, 98% correctly identified heroin as a drug typically injected, and 93% identified Hepatitis C as an infectious risk of IDU. 63% of respondents use harm reduction strategies every few months or less. 34% prescribe buprenorphine routinely, and 76% prescribe pre-exposure prophylaxis to those at risk for Human Immunodeficiency Virus (HIV). 76% are comfortable discussing IDU with their patients, but 59% indicate that they lack the necessary skills, and 42% agree that they lack the time to address it. Conclusion Knowledge of IDU was adequate among those surveyed, although overall utilization of harm reduction was infrequent. There is a perceived deficit in skills and time to effectively provide harm reduction to primary care patients in the San Fernando Valley.
引用
收藏
页数:7
相关论文
共 43 条
  • [21] Phone-call and Linkage-to-care-based Intervention Increases Mammography Uptake Among Primary Care Patients at an Urban Safety-net Hospital
    Nanda, Asha
    Mann, Melissa
    Cooper, Carmella
    Frederick, Melinda
    Cheng, An-Lin
    Moormeier, Jill
    Ahmadiyeh, Nasim
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S267 - S268
  • [22] Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers
    Ivers, Jo-Hanna
    Killeen, Nicki
    Keenan, Eamon
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (04) : 1701 - 1710
  • [23] Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers
    Jo-Hanna Ivers
    Nicki Killeen
    Eamon Keenan
    Irish Journal of Medical Science (1971 -), 2022, 191 : 1701 - 1710
  • [24] Prescription drug use and costs among diabetic patients in primary health care practices in Germany
    Rathmann, W
    Haastert, B
    Roseman, JM
    Gries, FA
    Giani, G
    DIABETES CARE, 1998, 21 (03) : 389 - 397
  • [25] Academic detailing increases prescription drug monitoring program use among primary care practices
    Carico, Ron, Jr.
    West, Ryan
    Miller, Tiffany
    Brown, Jessica
    Baum, Dustin
    Dunaway, Sarah
    Hill, Alexander
    Finley, Will
    Bates, Jesse
    Fenerty, Jeff
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2021, 61 (04) : 425 - 431
  • [26] Drug use practices among people who inject drugs in a context of drug market changes: Challenges for optimal coverage of harm reduction programs
    Roy, Elise
    Arruda, Nelson
    Leclerc, Pascale
    Morissette, Carole
    Blanchette, Caty
    Blouin, Karine
    Alary, Michel
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 45 : 18 - 24
  • [27] NO DETECTABLE EFFECT OF MARIJUANA USE ON HEALTH OR HEALTHCARE UTILIZATION AMONG PATIENTS WITH ANY ILLICIT DRUG USE IDENTIFIED BY SCREENING IN PRIMARY CARE
    Fuster, Daniel
    Cheng, Debbie M.
    Allensworth-Davis, Donald
    Palfai, Tibor P.
    Samet, Jeffrey H.
    Saitz, Richard
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S253 - S253
  • [28] Effect of Patient Navigation and Financial Incentives on Smoking Cessation Among Primary Care Patients at an Urban Safety-Net Hospital A Randomized Clinical Trial
    Lasser, Karen E.
    Quintiliani, Lisa M.
    Ve Truong
    Xuan, Ziming
    Murillo, Jennifer
    Jean, Cheryl
    Pbert, Lori
    JAMA INTERNAL MEDICINE, 2017, 177 (12) : 1798 - 1807
  • [29] Differences by race and ethnicity in drug use patterns, harm reduction practices and barriers to treatment among people who use drugs in Rhode Island
    Parker, Samantha
    Reichley, Nya
    Biello, Katie B.
    Goldman, Jacqueline
    Buxton, Jane A.
    Hadland, Scott E.
    Sherman, Susan G.
    Marshall, Brandon D. L.
    Macmadu, Alexandria
    HARM REDUCTION JOURNAL, 2025, 22 (01)
  • [30] THE ASSOCIATION BETWEEN RESILIENCY AND DIABETES SELF-MANAGEMENT AMONG AFRICAN-AMERICAN MEN RECEIVING PRIMARY CARE AT AN URBAN SAFETY-NET HOSPITAL
    Jenkins, Andrew
    Quintiliani, Lisa M.
    Ve Truong
    Lasser, Karen E.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S354 - S354